TherapeuticsMD, Inc. (TXMD) Forms $5.35 Double Top; Mcewen Mining (MUX) Sellers Increased By 0.19% Their Shorts

March 13, 2018 - By Jerrie Dane

TherapeuticsMD, Inc. (TXMD) formed double top with $5.78 target or 8.00% above today’s $5.35 share price. TherapeuticsMD, Inc. (TXMD) has $1.16 billion valuation. The stock decreased 2.19% or $0.12 during the last trading session, reaching $5.35. About 1.86 million shares traded. TherapeuticsMD, Inc. (NASDAQ:TXMD) has declined 46.30% since March 13, 2017 and is downtrending. It has underperformed by 63.00% the S&P500.

Mcewen Mining Inc (NYSE:MUX) had an increase of 0.19% in short interest. MUX’s SI was 44.63 million shares in March as released by FINRA. Its up 0.19% from 44.55 million shares previously. With 3.71 million avg volume, 12 days are for Mcewen Mining Inc (NYSE:MUX)’s short sellers to cover MUX’s short positions. The SI to Mcewen Mining Inc’s float is 17.83%. The stock increased 0.99% or $0.02 during the last trading session, reaching $2.04. About 2.31 million shares traded. McEwen Mining Inc. (NYSE:MUX) has risen 12.45% since March 13, 2017 and is uptrending. It has underperformed by 4.25% the S&P500.

McEwen Mining Inc. explores for, develops, produces, and sells gold, silver, and copper ores in Argentina, Mexico, and the United States. The company has market cap of $687.59 million. The Company’s principal asset consists of a 49% interest in the San José mine in Santa Cruz, Argentina. It currently has negative earnings. The companyÂ’s principal assets also include 100% interest in the El Gallo 1 mine and El Gallo 2 project in Sinaloa, Mexico; the Gold Bar project in Nevada, the United States; and the Los Azules copper project in San Juan, Argentina.

Among 2 analysts covering McEwen Mining (NYSE:MUX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. McEwen Mining had 10 analyst reports since July 18, 2017 according to SRatingsIntel. H.C. Wainwright maintained McEwen Mining Inc. (NYSE:MUX) rating on Tuesday, January 16. H.C. Wainwright has “Buy” rating and $5.0 target. The stock of McEwen Mining Inc. (NYSE:MUX) earned “Buy” rating by H.C. Wainwright on Wednesday, October 11. H.C. Wainwright maintained McEwen Mining Inc. (NYSE:MUX) on Tuesday, July 18 with “Buy” rating. The rating was maintained by Roth Capital with “Buy” on Tuesday, January 16. The stock has “Buy” rating by H.C. Wainwright on Thursday, November 9. As per Thursday, August 3, the company rating was maintained by H.C. Wainwright. H.C. Wainwright maintained it with “Buy” rating and $500 target in Friday, August 11 report. H.C. Wainwright maintained McEwen Mining Inc. (NYSE:MUX) on Friday, November 3 with “Buy” rating. The rating was maintained by H.C. Wainwright on Thursday, October 19 with “Buy”.

Investors sentiment decreased to 1.62 in Q3 2017. Its down 0.11, from 1.73 in 2017Q2. It dived, as 9 investors sold TherapeuticsMD, Inc. shares while 28 reduced holdings. 24 funds opened positions while 40 raised stakes. 162.04 million shares or 5.51% more from 153.57 million shares in 2017Q2 were reported. State Board Of Administration Of Florida Retirement has 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). Massachusetts Ma has 443,294 shares for 0% of their portfolio. J Goldman And Ltd Partnership holds 0.22% or 814,500 shares. 113,000 were accumulated by State Of Wisconsin Inv Board. 432,967 were accumulated by Morgan Stanley. Principal Fincl Gru Incorporated has 18,406 shares for 0% of their portfolio. Wells Fargo Commerce Mn has 217,820 shares. Cubist Systematic Strategies Limited Liability Corporation invested in 10,340 shares or 0% of the stock. Sta Wealth Ltd Llc invested 0.03% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Price T Rowe Associates Md has invested 0.01% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Berson And Corrado Inv Advisors Llc invested in 53,125 shares. Amalgamated Bankshares owns 19,940 shares. Savings Bank Of America Corporation De holds 0% of its portfolio in TherapeuticsMD, Inc. (NASDAQ:TXMD) for 26,569 shares. Bluecrest Capital Management Limited holds 0% of its portfolio in TherapeuticsMD, Inc. (NASDAQ:TXMD) for 14,580 shares. Greenwood Ltd Liability Co accumulated 0.08% or 58,968 shares.